Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin (Q28143430)

2

0 references

C M Dersch

3

0 references

D V Romero

4

0 references

K C Rice

5

0 references

F I Carroll

6

0 references

J S Partilla

Dopaminergic agonist properties of ephedrine-theoretical implications

7

0 references

language of work or name

English

0 references

publication date

January 2001

0 references

published in

Synapse

0 references

volume

39

0 references

issue

1

0 references

page(s)

32-41

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Alterations in serotonergic responsiveness during cocaine withdrawal in rats: similarities to major depression in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

High dose pimozide does not block amphetamine-induced euphoria in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Dopamine ligands and the stimulus effects of amphetamine: animal models versus human laboratory data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Factors influencing the reinforcing and subjective effects of ephedrine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Flunarizine attenuates cocaine-induced inhibition of A9 dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Treatment of attention-deficit-hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Biological and behavioral responses to D-amphetamine, alone and in combination with the serotonin3 receptor antagonist ondansetron, in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Discriminative stimulus effects of d-amphetamine, methylphenidate, and diazepam in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

The dopamine hypothesis of the reinforcing properties of cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Effect of acute, short- and long-term milnacipran administration on rat locus coeruleus noradrenergic and dorsal raphe serotonergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Effect of dopamine receptor antagonists on cocaine subjective effects: a naturalistic case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Extracellular dopamine, norepinephrine, and serotonin in the ventral tegmental area and nucleus accumbens of freely moving rats during intracerebral dialysis following systemic administration of cocaine and other uptake blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Cocaine receptors on dopamine transporters are related to self-administration of cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Phentermine and Fenfluramine: Preclinical Studies in Animal Models of Cocaine Addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Studies of the biogenic amine transporters. VII. Characterization of a novel cocaine binding site identified with [125I]RTI-55 in membranes prepared from human, monkey and guinea pig caudate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Differential effects of the enantiomers R(-) and S(+) oxaprotiline on major endogenous depression, the sleep EEG and neuroendocrine secretion: studies on depressed patients and normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [11C] WIN35,428 PET scans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Neurobiology of addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

Evaluation of the abuse liability of aminorex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1098-2396%2820010101%2939%3A1%3C32%3A%3AAID-SYN5%3E3.0.CO%3B2-3

10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3

21 January 2018

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

11071707

1 reference

Consolidated OpenCitations Corpus – April 2017